HC Wainwright & Co. Initiates Coverage On ProKidney with Buy Rating, Announces Price Target of $12
Benzinga Newsdesk 10 months ago
NewsPrice TargetInitiationAnalyst Ratings
HC Wainwright & Co. analyst Joseph Pantginis initiates coverage on ProKidney (NASDAQ:PROK) with a Buy rating and announces Price Target of $12.
HC Wainwright & Co. analyst Joseph Pantginis initiates coverage on ProKidney (NASDAQ:PROK) with a Buy rating and announces Price Target of $12.